利索-全球专利检索

  1. 登录
  2. 注册
发明申请
US20160346312A1 INTRAPULMONARY ADMINISTRATION OF POLYNUCLEOTIDE TOLL-LIKE RECEPTOR 9 AGONISTS FOR TREATING CANCER OF THE LUNG 有权
多核胆固醇受体诱导治疗肺癌癌症的药物治疗

INTRAPULMONARY ADMINISTRATION OF POLYNUCLEOTIDE TOLL-LIKE RECEPTOR 9 AGONISTS FOR TREATING CANCER OF THE LUNG
摘要：
The present disclosure relates to methods for treating cancer by intrapulmonary administration of a polynucleotide Toll-like receptor 9 agonist. The methods of the present disclosure are suitable for treating primary cancer of the lung, as well as metastatic cancer to the lung and extra pulmonary cancers thereof. Additionally, the present disclosure provides polynucleotide Toll-like receptor 9 agonists with immune stimulatory and toxicity profiles suitable for intrapulmonary administration.
摘要（中）：

本公开涉及通过肺内施用多核苷酸Toll样受体9激动剂治疗癌症的方法。 本公开的方法适用于治疗肺的原发性癌症，以及肺转移性癌症及其额外的肺癌。 另外，本公开提供具有适于肺内给药的免疫刺激和毒性特征的多核苷酸Toll样受体9激动剂。

公开/授权文献
信息查询
Global Dossier Espacenet
0/0